Incidence of stroke in people with Alzheimer disease: A national register-based approach

Neurology

Volumn 80, Issue 4, 2013, Pages 353-358

  Tolppanen, Anna Maija ^a   Lavikainen, Piia ^c   Solomon, Alina ^a,d   Kivipelto, Miia ^a,d   Soininen, Hilkka ^a,e   Hartikainen, Sirpa ^b,c  

^a Institute of Clinical Medicine   (Finland)

^b Clinical Pharmacology and Geriatric Pharmacotherapy Unit   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FINLAND; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; REIMBURSEMENT; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COHORT STUDIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; STROKE;

EID: 84873615101     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31827f08c5     Document Type: Article

References (27)

1. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007;69:2197-2204.
2. Hayden KM, Zandi PP, Lyketsos CG, et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: the cache county study. Alzheimer Dis Assoc Disord 2006;20: 93-100.
3. Lenzi GL, Altieri M. Short-term evolution as a marker of vascular dementia versus Alzheimer's disease. J Neurol Sci 2007;257:182-184.
4. Rastas S, Verkkoniemi A, Polvikoski T, et al. Atrial fibrillation, stroke, and cognition: a longitudinal population-based study of people aged 85 and older. Stroke 2007;38:1454-1460.
5. Reitz C, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM. Prestroke cognitive performance, incident stroke, and risk of dementia: the rotterdam study. Stroke 2008;39: 36-41.
6. Savva GM, Stephan BC; Alzheimer's Society Vascular Dementia Systematic Review Group. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 2010;41:e41-e46.
7. Treiber KA, Lyketsos CG, Corcoran C, et al. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the cache county study. Int Psychogeriatr 2008;20:538-553.
8. Regan C, Katona C, Walker Z, Hooper J, Donovan J, Livingston G. Relationship of vascular risk to the progression of Alzheimer disease. Neurology 2006;67:1357-1362.
9. Schneider JA, Bennett DA. Where vascular meets neurodegenerative disease. Stroke 2010;41:S144-S146.
10. Dede DS, Yavuz B, Yavuz BB, et al. Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease? J Am Geriatr Soc 2007;55:1613-1617.
11. Bell RD, Zlokovic BV. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009;118:103-113.
12. Iadecola C, Park L, Capone C. Threats to the mind: aging, amyloid, and hypertension. Stroke 2009;40:S40-S44.
13. Kawai M, Kalaria RN, Cras P, et al. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 1993;623:142-146.
14. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA 1997;277:813-817.
15. Cadavid D, Mena H, Koeller K, Frommelt RA. Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction: a case control study in human brain biopsies. JNeuropathol Exp Neurol 2000;59:768-773.
16. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995;52:702-708.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
19. Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 2011;10: 785-796.
20. van der Flier WM, Pijnenburg YA, Fox NC, Scheltens P. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE varepsilon4 allele. Lancet Neurol 2011;10: 280-288.
21. Kokjohn TA, Van Vickle GD, Maarouf CL, et al. Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets. Biochim Biophys Acta 2011;1812:1508-1514.
22. Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 2004;363:1139-1146.
23. Dik MG, Deeg DJ, Bouter LM, Corder EH, Kok A, Jonker C. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: a population-based study. Stroke 2000;31:2431-2436.
24. Mielke MM, Leoutsakos JM, Tschanz JT, et al. Interaction between vascular factors and the APOE epsilon4 allele in predicting rate of progression in Alzheimer's disease. J Alzheimers Dis 2011;26:127-134.
25. Meretoja A, Kaste M, Roine RO, et al. Trends in treatment and outcome of stroke patients in Finland from 1999 to 2007: PERFECT stroke, a nationwide register study. Ann Med 2011;43(suppl 1):S22-S30.
26. Tolonen H, Salomaa V, Torppa J, et al. The validation of the Finnish Hospital Discharge Register and Causes of Death Register data on stroke diagnoses. Eur J Cardiovasc Prev Rehabil 2007;14:380-385.
27. Suhonen J, Pirttilä T, Erkinjuntti T, et al. Update on current care guidelines: the diagnosis and medical treatment of memory disorders [in Finnish]. Duodecim 2010; 126:2167-2168.